Related Experiment Video
Updated: Apr 27, 2026
A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
N-[3-(aminomethyl)benzyl]acetamidine (1400 W) as a potential immunomodulatory agent
Anna Mertas1, Hanna Duliban2, Ewelina Szliszka1
1Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Jordana 19, 41 808 Zabrze, Poland.
Abstract:
This study was designed to investigate the relationship between NO, IL-12, and TNF-α production by J774A.1 macrophages activated with LPS and IFN-γ in the presence of N-[3-(aminomethyl)benzyl]acetamidine (1400 W). 1400 W is a novel, highly selective inhibitor of inducible nitric oxide synthase (iNOS). We compared the obtained data with the effect of N(G)-monomethyl-L-arginine (L-NMMA) (a nonselective NOS inhibitor) and L-N(G)-(1-iminoethyl)lysine (L-NIL) (a relatively selective inhibitor of iNOS activity) on cells in this model. To investigate the involvement of an exogenous NO on IL-12 and TNF-α production we used NO donor-S-nitrosocaptopril (S-NO-Cap). The most potent inhibitor of NO generation was 1400 W. This compound also markedly increased IL-12 p40 secretion and decreased TNF-α release. L-NIL suppressed both NO and TNF-α production, but it did not change IL-12 p40 synthesis. The effect of L-NMMA on NO generation was weaker than other inhibitors. Moreover, it decreased TNF-α secretion slightly but not significantly. IL-12 p40 production by stimulated cells was inhibited by S-NO-Cap in a dose dependent manner, but no effect on TNF-α release was observed. The potency and selectivity of 1400 W as an inhibitor of iNOS and cytokine release modifier are encouraging for therapeutic use.
Insights
The selective inducible nitric oxide synthase (iNOS) inhibitor 1400W effectively reduced nitric oxide (NO) and tumor necrosis factor-alpha (TNF-α) while increasing interleukin-12 (IL-12) production in macrophages.
Area of Science:
- Immunology
- Pharmacology
Background:
- Macrophages play a critical role in immune responses.
- Nitric oxide (NO), IL-12, and TNF-α are key inflammatory mediators.
- Inducible nitric oxide synthase (iNOS) is a crucial enzyme in NO production.
Purpose of the Study:
- To investigate the effects of selective iNOS inhibitors on NO, IL-12, and TNF-α production.
- To compare the efficacy of 1400W, L-NIL, and L-NMMA on cytokine release.
- To explore the role of exogenous NO in modulating IL-12 and TNF-α production.
Main Methods:
- J774A.1 macrophages were activated with LPS and IFN-γ.
- Cells were treated with iNOS inhibitors: 1400W, L-NMMA, and L-NIL.
- NO production was measured, along with IL-12 p40 and TNF-α secretion.
- The effect of NO donor S-NO-Cap on cytokine production was assessed.
Main Results:
- 1400W potently inhibited NO generation and decreased TNF-α release while increasing IL-12 p40 secretion.
- L-NIL suppressed NO and TNF-α but did not affect IL-12 p40.
- L-NMMA showed weaker inhibition of NO and a non-significant decrease in TNF-α.
- Exogenous NO (S-NO-Cap) inhibited IL-12 p40 production in a dose-dependent manner.
Conclusions:
- 1400W demonstrates significant potential as a therapeutic agent for modulating iNOS activity and cytokine profiles.
- Selective iNOS inhibition offers a promising strategy for managing inflammatory conditions.
- The distinct effects of different NOS inhibitors highlight the complexity of NO-mediated immune regulation.
More Related Videos
07:04Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
Published on: September 16, 2018
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
